Birt-Hogg-Dubé Syndrome (PDQ®): Health Professional Version
- PMID: 33724752
- Bookshelf ID: NBK568510
Birt-Hogg-Dubé Syndrome (PDQ®): Health Professional Version
Excerpt
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the genetics of Birt-Hogg-Dubé syndrome (BHD). It is intended as a resource to inform and assist clinicians who care for BHD patients. It does not provide formal guidelines or recommendations for making health care decisions.
This summary is reviewed regularly and updated as necessary by the PDQ Cancer Genetics Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).
Keywords: Birt-Hogg-Dubé syndrome; cancer genetics.
Sections
- Introduction
- Genetics
- Molecular Biology
- Clinical Manifestations
- Risk Assessment for Birt-Hogg-Dubé Syndrome (BHD)
- Surveillance for Birt-Hogg-Dubé Syndrome (BHD)
- Management of Disease Manifestations for Birt-Hogg-Dubé Syndrome (BHD)
- Prognosis
- Future Directions
- Latest Updates to This Summary (12/16/2024)
- About This PDQ Summary
References
-
- Nickerson ML, Warren MB, Toro JR, et al.: Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2 (2): 157-64, 2002. - PubMed
-
- Birt AR, Hogg GR, Dubé WJ: Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113 (12): 1674-7, 1977. - PubMed
-
- Boza JC, Trindade EN, Peruzzo J, et al.: Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol 26 (10): 1220-3, 2012. - PubMed
Publication types
LinkOut - more resources
Full Text Sources